COVID-19 - Funding Opportunities

COVID-19 - Funding Opportunities

In the following, we summarise funding opportunities concerning the COVID-19 pandemic.

BioM supports biopharmaceutical companies in implementing their ideas and projects. Therefore, we are happy to help you find the right funding programmes and contact persons. Please contact us at info@remove-this.bio-m.org.

National Funding Information

Bundesministerium für Bildung und Forschung (BMBF)
Coronavirus: Advice and administration

Guideline to support clinical development of supply-related COVID-19 drugs and their manufacturing capabilities (Deadline: June 25, 2021)

Guideline for the funding of research projects on late symptoms of COVID-19 (Long-Covid). (Deadline: July 14, 2021)

Guideline for funding research and development of urgently needed therapeutics against SARS-CoV-2 (Deadline: August 23, 2021)

Special programme to accelerate research and development of urgently needed vaccines against SARS-CoV-2

4th Call Computational Life Sciences - AI Methods for Infection Research

Nationale Kontaktstelle Lebenswissenschaften
Overview of COVID-19 funding programs

EU-Funding Opportunities

EU Commission - Horizon 2020

European Research Area (ERA) corona platform

The Research Executive Agency (REA) provides information on the effects on application submission, review and project processing in Horizon 2020 . Information is available on MSC-measures.

HERA Incubator
European bio-defence preparedness plan against COVID-19 variants

Special measures for health-related approaches to COVID-19 (Deadline: 6.Mai 2021):
Cohorts united against COVID-19 variants of concern

Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment

FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases

Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics

Other Funding Opportunities

Novartis
Broad range of initiatives to respond to COVID-19 Pandemic

Blumorpho und EuroScan
Together against the Covid-19 pandemic

Science|Business
Science|Business Database: Coronavirus Funding Opportunities

JEDI (Joint European Disruptive Initiative)
Billion Molecules against COVID-19 Grand Challenge

Creative Destruction Lab
CDL Recovery

Dr. Petra Burgstaller
Dr. Petra Burgstaller

Head of inQlab


Christina Enke-Stolle
Christina Enke-Stolle

Head of inQlab